Ryman Healthcare Limited (RYHTY)
OTCMKTS · Delayed Price · Currency is USD
8.00
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT
Ryman Healthcare Market Cap
Ryman Healthcare has a market cap or net worth of $1.67 billion as of October 30, 2025. Its market cap has decreased by -19.74% in one year.
Market Cap
1.67B
Enterprise Value
2.64B
Revenue
430.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
$8.00
Market Cap Chart
Since June 6, 2000, Ryman Healthcare's market cap has increased from 81.02M to 1.67B, an increase of 1,964.40%. That is a compound annual growth rate of 12.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 1.67B | -7.57% |
| Dec 31, 2024 | 1.81B | -29.31% |
| Dec 29, 2023 | 2.56B | 49.85% |
| Dec 30, 2022 | 1.71B | -59.03% |
| Dec 31, 2021 | 4.17B | -23.30% |
| Dec 31, 2020 | 5.44B | -0.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 648.67M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 341.50M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 303.60M |
| American Oncology Network | 297.14M |